Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,958 total articles
Genius Group Limited (NYSE American: GNS) announced the purchase of over 6 million Class A Ordinary Shares in a privately negotiated deal, following a recent 6.6 million share buyback. These transactions contribute to the removal of 32.6 million shares from the company's issued capital within eight days, equating to 27% of the public float, aiming …
Kyverna Therapeutics has appointed Ritesh Srivastava as Chief Legal and Compliance Officer to support its advancement towards potential commercialization of its lead CAR T-cell therapy, miv-cel, targeting autoimmune diseases such as stiff person syndrome. The appointment strengthens the company's executive team as it plans to transition into a comm…
Lifetime Brands, Inc. reported the outcomes of its 2026 Annual Meeting of Stockholders, including director elections, ratification of Ernst & Young LLP as auditor, approval of 2025 executive compensation, and amendment to its Long-Term Incentive Plan. The company also declared a quarterly cash dividend of $0.0425 per share.
GrowGeneration Corp., a leading supplier of specialty products for controlled environment agriculture and commercial cultivation, announced that CEO Darren Lampert will present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 23, 2026. The company highlights its broad product offerings and business segments during this e…
Autonomix Medical announced successful preclinical development of a proprietary standalone neural sensing platform capable of detecting renal nerve activity and real-time changes following intervention. Built on the same technology as their pancreatic cancer pain program, this platform offers a capital-efficient path into cardiology, particularly r…
Hyperion DeFi, the first U.S. publicly listed DeFi company on Hyperliquid, announced a partnership with Blockdaemon to support Hyperliquid staking operations via the Kinetiq X Hyperion Validator. This collaboration aims to expand institutional access and infrastructure in the growing Hyperliquid decentralized trading ecosystem. The partnership enab…
Nasus Pharma Ltd., a clinical-stage pharmaceutical company specializing in intranasal powder drug delivery technology, announced its participation at the upcoming Zacks Life Sciences Investor Forum. The management will present their innovative intranasal products, including their needle-free epinephrine alternative NS002, and engage with investors …
Revolution Medicines announces that Steve Kelsey, President of Research and Development, will transition to a senior advisor role effective July 1, 2026, ahead of his planned retirement in January 2027. The company also reveals a new R&D leadership structure to ensure ongoing strategic execution. Kelsey has played a key role in advancing the compan…
Prime Medicine announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational therapy PM359 for the treatment of p47phox-deficient chronic granulomatous disease (CGD). This designation, based on promising Phase 1/2 clinical data, enables early FDA engagement and expedited review pathways, reinfor…
Taysha Gene Therapies announced the completion of dosing in its REVEAL pivotal trial evaluating TSHA-102 for Rett syndrome and reported positive longer-term clinical data from earlier phases. The gene therapy showed durable, clinically meaningful functional gains with no treatment-related serious adverse events. The company plans to submit a Biolog…
Praxis Precision Medicines has received FDA Breakthrough Therapy Designation (BTD) for elsunersen (PRAX-222), an antisense oligonucleotide targeting seizures in patients with SCN2A Developmental and Epileptic Encephalopathy (SCN2A-DEE) due to gain-of-function variants. The designation was based on positive results from the EMBRAVE Part A trial, whi…
Catheter Precision, Inc. announced the issuance of eight new patents related to heart failure technologies and three new patents for its vascular closure device, LockeT, in the US and international markets. These patents enhance the Company's portfolio and support ongoing discussions around potential sales of these technologies, reinforcing their m…
Sonoco Products Company, a global leader in sustainable packaging, will report its Q2 2026 financial results on July 22, 2026 after market close, followed by a conference call on July 23. The company highlights its strong operational footprint and recent accolades in sustainability and corporate responsibility.
Upexi, Inc., a Nasdaq-listed company specializing in Solana-based digital asset treasury and consumer brands, announced a private placement raising approximately $19.5 million by issuing over 12 million shares at about $1.60 each. The proceeds are used to reduce existing debt. The offering was made without a placement agent and complies with securi…
Castor Maritime Inc., a NASDAQ-listed diversified global shipping and energy company, announced the agreement to acquire a modern 2023-built eco-friendly Kamsarmax bulk carrier for $37.5 million. The vessel acquisition, expected to close by the end of the quarter, will expand the company's fleet to 10 vessels, enhancing its dry bulk shipping capaci…
BridgeBio Pharma announced that positive primary results from its Phase 3 PROPEL 3 trial of oral infigratinib in children with achondroplasia will be presented at the International Congress of Children's Bone Health (ICCBH) 2026. The company will also share additional research findings on quality of life, early intervention, and disease monitoring …
BrainsWay Ltd., a leader in advanced noninvasive brain stimulation technologies, announced significant expansion in favorable medical coverage across the U.S. for its SWIFT Accelerated Deep TMS protocol. Eight major payers and the US Department of Veterans Affairs now cover or support this treatment, impacting over 57 million covered lives. The cov…
Medicus Pharma Ltd., a Nasdaq-listed biotech company, announced its participation in the 2026 Bio International Conference to present advancements in its clinical development programs for SkinJect®, an innovative treatment for basal cell carcinoma and Gorlin Syndrome, and Teverelix®, a next-generation GnRH antagonist targeting prostate cancer, acut…
Streamex Corp. (NASDAQ: STEX) announced the May 2026 yield dividend distribution for GLDY, its gold-backed yield-bearing tokenized security. The distribution covers the period from May 1 to May 31, 2026, with GLDY holders receiving 0.002884 GLDY per token, representing an annualized yield of 3.5% generated via Streamex's institutional gold leasing …
Palvella Therapeutics announced that the FDA has granted rolling review for its New Drug Application (NDA) for QTORIN™ rapamycin, aimed at treating microcystic lymphatic malformations, a rare and serious skin disease with no existing FDA-approved therapies. The company expects to complete NDA submission in late 2026, leveraging FDA designations to …
SL Green Realty Corp., Manhattan's largest office landlord and a leading REIT, will release its financial results for the second quarter of 2026 after market close on July 22, 2026. The company will host a conference call and webcast on July 23, 2026 to discuss these results, with supplemental financial data made available concurrently on its websi…
Nuvectis Pharma has entered an exclusive licensing agreement with Haisco Pharmaceutical Group to acquire ex-China rights to two late-stage clinical compounds: NXP100, a once-daily oral Complement Factor B inhibitor targeting complement-mediated diseases including PNH, IgAN, and LN; and NXP200, a paradox-breaker BRAF inhibitor for BRAF-mutated malig…
Quantum Cyber N.V. updates shareholders on recent strategic developments including high-level engagements with U.S. government officials, a defense and military conference, progress toward acquiring a Connecticut manufacturing facility for drone production, and improved financial strength with over $15 million raised from warrant exercises, positio…
Edible Garden AG Incorporated announced that its Pickle Party™ product line was named the 2026 Mindful Award Winner for Overall Plant-Based Snack Product of the Year. The award recognizes innovation, sustainability, product quality, and mindful consumer impact. Pickle Party™ is a unique line of raw, fermented, non-GMO, clean-label pickles and kraut…
DMC Global Inc.'s NobelClad business has expanded its manufacturing capabilities in the Americas by adding weld overlay services. This new turnkey service complements NobelClad's existing clad metal solutions by enhancing corrosion resistance and wear protection for critical industrial equipment, particularly in the oil and gas, chemical processing…
